KRAS and cancer: KRAS4B (hereafter simply referred to as KRAS) is the most prevalent RAS isoform in cancer, with its oncogenic mutants found in ~80% of all RAS-dependent tumors, especially in 98% of pancreatic, 45% of colorectal and 31% of lung tumors [1,2,3,6].